Comparison of Dexmedetomidine and Propofol on the Delirium and Neuroinflammation in Patients With SIRS.

• Status: Withdrawn
• Trial end date: 2018-12-01
• Target enrollment: 0
• Participant gender: All

Summary

Assessment of sedative effects of dexmedetomidine and propofol on the clinical course of delirium and neuroinflammation in patients with SIRS using CAM-ICU scale and protein S100b in serum.

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Moscow Regional Research and Clinical Institute Moniki n.a. M.F. Vladimirskiy
• Treatments: Dexmedetomidine; Propofol

Criteria

Inclusion Criteria:

• presence of delirium

Exclusion Criteria:

• presence of Alzheimer's disease

• any mental disorder

• presence of cancer